Preclinical Imaging Market: Current Analysis and Forecast (2021-2027)

Preclinical Imaging Market: Current Analysis and Forecast (2021-2027)

The Global Preclinical Imaging Market is anticipated to grow with an elevated CAGR of around 5% over the forecast period (2021-2027). Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Researchers use imaging to observe changes, at the organ, tissue, cell, or molecular level, in animals’ response to physiological or environmental changes.

The rising prevalence of chronic diseases and the increasing geriatric population are the contributing factors to the increasing demand for the research & development of the new drugs. Furthermore, the surging incidences of genetic and orphan diseases rise the demand for the development of the novel treatment which results in the growth of the preclinical imaging market. For instance, as per the Health department of Australia, Approximately 6 out of 10 people will be affected by a condition that has some genetic background. Genetic conditions can range from mild to very severe. Genetic conditions and birth defects occur in between 3 and 5 percent of babies born in Western Australia.

Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Mediso Ltd., Agilent Technologies, MILabs B.V., and MR solutions. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Preclinical Imaging.

Insights Presented in the Report
"Amongst product, multi-modal imaging holds the major share”

Based on the product, the market is segmented into CT imaging, MRI imaging, PET/SPECT imaging, multi-modal imaging, optical imaging, ultrasound imaging, photoacoustic imaging, reagents, and services. The multi-modal imaging held a significant market share and is anticipated to witness significant growth during the forecast period. The increasing adoption of multimodal imaging because these systems use different imaging techniques for disease analysis is one of the factors that positively affects the market for preclinical imaging. Furthermore, the rising demand from government institutions for the research also increases the market for multi-modal imaging. For instance, in November 2021, the Union Minister of State (Independent Charge) for the Ministry of Science and Technology, Dr. Jitendra Singh inaugurated the project SWADESH. The project SWADESH is the first-of-its-kind large-scale multimodal neuroimaging database designed specifically for the Indian population.
"Amongst application, cardiology holds the major share”

Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases, and others. the cardiology segment is expected to witness lucrative growth during the forecast period. This is mainly due to the rapidly increasing cases of heart disease owing to the segmental growth of cardiology in the preclinical imaging market. For instance, One person dies every 36 seconds in the United States from cardiovascular disease. About 659,000 people in the United States die from heart disease each year—that’s 1 in every 4 deaths.
"North America represents one of the largest markets of Preclinical Imaging market”

For a better understanding of the market dynamics of the Preclinical Imaging market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America grabbed a significant market share of the global market. It is expected to grow with considerable CAGR during the forecast period (2021-2027F). The major factors such as the presence of well-established research infrastructure and major market players along with frequent product launches are responsible for the regional growth in the preclinical imaging market. For instance, in May 2022, Bruker announced the launch of 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. The Maxwell 7 Tesla and 9.4 Tesla magnets eliminate the need for liquid helium or nitrogen refills while offering high-field sensitivity and resolution for advanced preclinical MRI and PET/MR research.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry